165 related articles for article (PubMed ID: 32116196)
1. A Comparative Study of 1D Descriptors Supported CoMFA and CoMSIA QSAR Models to Gain Novel Insights into 1,2,4-Triazoles Acting As Antitubercular Agents.
Ray R; Shenoy GG; Kumar TNVG
Curr Comput Aided Drug Des; 2021; 17(2):281-293. PubMed ID: 32116196
[TBL] [Abstract][Full Text] [Related]
2. CoMFA and CoMSIA 3D-QSAR analysis of diaryloxy-methano-phenanthrene derivatives as anti-tubercular agents.
Shagufta ; Kumar A; Panda G; Siddiqi MI
J Mol Model; 2007 Jan; 13(1):99-109. PubMed ID: 16858589
[TBL] [Abstract][Full Text] [Related]
3. 3D-QSAR study of ring-substituted quinoline class of anti-tuberculosis agents.
Nayyar A; Malde A; Jain R; Coutinho E
Bioorg Med Chem; 2006 Feb; 14(3):847-56. PubMed ID: 16214351
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, in vitro antitubercular activity and 3D-QSAR study of 1,4-dihydropyridines.
Manvar AT; Pissurlenkar RR; Virsodia VR; Upadhyay KD; Manvar DR; Mishra AK; Acharya HD; Parecha AR; Dholakia CD; Shah AK; Coutinho EC
Mol Divers; 2010 May; 14(2):285-305. PubMed ID: 19554465
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, screening for antitubercular activity and 3D-QSAR studies of substituted N-phenyl-6-methyl-2-oxo-4-phenyl-1,2,3,4-tetrahydro-pyrimidine-5-carboxamides.
Virsodia V; Pissurlenkar RR; Manvar D; Dholakia C; Adlakha P; Shah A; Coutinho EC
Eur J Med Chem; 2008 Oct; 43(10):2103-15. PubMed ID: 17950956
[TBL] [Abstract][Full Text] [Related]
6. Structural insights of PA-824 derivatives: ligand-based 3D-QSAR study and design of novel PA824 derivatives as anti-tubercular agents.
Inturi B; Pujar GV; Purohit MN
J Recept Signal Transduct Res; 2015; 35(5):468-78. PubMed ID: 26053507
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and 3D-QSAR studies of new diphenylamine containing 1,2,4-triazoles as potential antitubercular agents.
Mohan Krishna K; Inturi B; Pujar GV; Purohit MN; Vijaykumar GS
Eur J Med Chem; 2014 Sep; 84():516-29. PubMed ID: 25055342
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, evaluation and CoMFA/CoMSIA study of nitrofuranyl methyl N-heterocycles as novel antitubercular agents.
Wang A; Yang Y; Jun Y; Wang B; Lv K; Liu M; Guo H; Lu Y
Bioorg Med Chem; 2018 May; 26(8):2073-2084. PubMed ID: 29551372
[TBL] [Abstract][Full Text] [Related]
9. Insights into the structural requirements of triazole derivatives as promising DPP IV inhibitors: computational investigations.
Shah BM; Sagar SR; Trivedi P
J Biomol Struct Dyn; 2022; 40(24):13778-13798. PubMed ID: 34738504
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and 3D-QSAR analysis of 2-chloroquinoline derivatives as H37 RV MTB inhibitors.
Khunt RC; Khedkar VM; Coutinho EC
Chem Biol Drug Des; 2013 Dec; 82(6):669-84. PubMed ID: 23790070
[TBL] [Abstract][Full Text] [Related]
11. CoMFA, CoMSIA and HQSAR Analysis of 3-aryl-3-ethoxypropanoic Acid Derivatives as GPR40 Modulators.
Gajjar KA; Gajjar AK
Curr Drug Discov Technol; 2020; 17(1):100-118. PubMed ID: 30160214
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, anti-tuberculosis activity, and 3D-QSAR study of 4-(adamantan-1-yl)-2-substituted quinolines.
Nayyar A; Monga V; Malde A; Coutinho E; Jain R
Bioorg Med Chem; 2007 Jan; 15(2):626-40. PubMed ID: 17107805
[TBL] [Abstract][Full Text] [Related]
13. 3D-QSAR and molecular docking study of LRRK2 kinase inhibitors by CoMFA and CoMSIA methods.
Pourbasheer E; Aalizadeh R
SAR QSAR Environ Res; 2016 May; 27(5):385-407. PubMed ID: 27228480
[TBL] [Abstract][Full Text] [Related]
14. Three-dimensional quantitative structure-activity relationship of 1,4-dihydropyridines as antitubercular agents.
Kharkar PS; Desai B; Gaveria H; Varu B; Loriya R; Naliapara Y; Shah A; Kulkarni VM
J Med Chem; 2002 Oct; 45(22):4858-67. PubMed ID: 12383011
[TBL] [Abstract][Full Text] [Related]
15. Docking-based 3D-QSAR (CoMFA, CoMFA-RG, CoMSIA) study on hydroquinoline and thiazinan-4-one derivatives as selective COX-2 inhibitors.
Dowlati Beirami A; Hajimahdi Z; Zarghi A
J Biomol Struct Dyn; 2019 Jul; 37(11):2999-3006. PubMed ID: 30035675
[TBL] [Abstract][Full Text] [Related]
16. 3D QSAR analysis of 2-(substituted aryl)-thiazolidine-4-carboxamides as potent antitubercular agents.
Nagasree KP; Kumar MM; Prasad YR; Sriram D; Yogeeswari P
Curr Comput Aided Drug Des; 2014; 10(3):274-81. PubMed ID: 25413596
[TBL] [Abstract][Full Text] [Related]
17. 3D-QSAR and molecular modeling studies on 2,3-dideoxy hexenopyranosid-4-uloses as anti-tubercular agents targeting alpha-mannosidase.
Shah P; Saquib M; Sharma S; Husain I; Sharma SK; Singh V; Srivastava R; Shaw AK; Siddiqi MI
Bioorg Chem; 2015 Apr; 59():91-6. PubMed ID: 25727263
[TBL] [Abstract][Full Text] [Related]
18. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Multiple Linear Regressions and Neural Networks based QSAR models for the design of new antitubercular compounds.
Ventura C; Latino DA; Martins F
Eur J Med Chem; 2013; 70():831-45. PubMed ID: 24246731
[TBL] [Abstract][Full Text] [Related]
20. New Research for Quinazoline-2,4-diones as HPPD Inhibitors Based on 2D-MLR and 3D-QSAR Models.
Fu Y; Sun YN; Cao HF; Yi KH; Zhao LX; Li JZ; Ye F
Comb Chem High Throughput Screen; 2017; 20(9):748-759. PubMed ID: 28637410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
